{
     "PMID": "28017918",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20170919",
     "LR": "20170919",
     "IS": "1879-1379 (Electronic) 0022-3956 (Linking)",
     "VI": "87",
     "DP": "2017 Apr",
     "TI": "Effects of ketamine administration on mTOR and reticulum stress signaling pathways in the brain after the infusion of rapamycin into prefrontal cortex.",
     "PG": "81-87",
     "LID": "S0022-3956(16)30738-5 [pii] 10.1016/j.jpsychires.2016.12.002 [doi]",
     "AB": "Recent studies show that activation of the mTOR signaling pathway is required for the rapid antidepressant actions of glutamate N-methyl-D-aspartate (NMDA) receptor antagonists. A relationship between mTOR kinase and the endoplasmic reticulum (ER) stress pathway, also known as the unfolded protein response (UPR) has been shown. We evaluate the effects of ketamine administration on the mTOR signaling pathway and proteins of UPR in the prefrontal cortex (PFC), hippocampus, amygdala and nucleus accumbens, after the inhibiton of mTOR signaling in the PFC. Male adult Wistar rats received pharmacological mTOR inhibitor, rapamycin (0.2 nmol), or vehicle into the PFC and then a single dose of ketamine (15 mg/kg, i.p.). The immunocontent of mTOR, eukaryotic initiation factor 4E-binding protein 1 (4E-BP1), eukaryotic elongation factor 2 kinase (eEF2K) homologous protein (CHOP), PKR-like ER kinase (PERK) and inositol-requiring enzyme 1 (IRE1) - alpha were determined in the brain. The mTOR levels were reduced in the rapamycin group treated with saline and ketamine in the PFC; p4EBP1 levels were reduced in the rapamycin group treated with ketamine in the PFC and nucleus accumbens; the levels of peEF2K were increased in the PFC in the vehicle group treated with ketamine and reduced in the rapamycin group treated with ketamine. The PERK and IRE1-alpha levels were decreased in the PFC in the rapamycin group treated with ketamine. Our results suggest that mTOR signaling inhibition by rapamycin could be involved, at least in part, with the mechanism of action of ketamine; and the ketamine antidepressant on ER stress pathway could be also mediated by mTOR signaling pathway in certain brain structures.",
     "CI": [
          "Copyright (c) 2016 Elsevier Ltd. All rights reserved."
     ],
     "FAU": [
          "Abelaira, Helena M",
          "Reus, Gislaine Z",
          "Ignacio, Zuleide M",
          "Dos Santos, Maria Augusta B",
          "de Moura, Airam B",
          "Matos, Danyela",
          "Demo, Julia P",
          "da Silva, Julia B I",
          "Michels, Monique",
          "Abatti, Mariane",
          "Sonai, Beatriz",
          "Dal Pizzol, Felipe",
          "Carvalho, Andre F",
          "Quevedo, Joao"
     ],
     "AU": [
          "Abelaira HM",
          "Reus GZ",
          "Ignacio ZM",
          "Dos Santos MA",
          "de Moura AB",
          "Matos D",
          "Demo JP",
          "da Silva JB",
          "Michels M",
          "Abatti M",
          "Sonai B",
          "Dal Pizzol F",
          "Carvalho AF",
          "Quevedo J"
     ],
     "AD": "Laboratorio de Neurociencias, Programa de Pos-Graduacao em Ciencias da Saude, Unidade Academica de Ciencias da Saude, Universidade do Extremo Sul Catarinense, Criciuma, Brazil. Laboratorio de Neurociencias, Programa de Pos-Graduacao em Ciencias da Saude, Unidade Academica de Ciencias da Saude, Universidade do Extremo Sul Catarinense, Criciuma, Brazil. Electronic address: gislainezilli@hotmail.com. Laboratorio de Neurociencias, Programa de Pos-Graduacao em Ciencias da Saude, Unidade Academica de Ciencias da Saude, Universidade do Extremo Sul Catarinense, Criciuma, Brazil. Laboratorio de Neurociencias, Programa de Pos-Graduacao em Ciencias da Saude, Unidade Academica de Ciencias da Saude, Universidade do Extremo Sul Catarinense, Criciuma, Brazil. Laboratorio de Neurociencias, Programa de Pos-Graduacao em Ciencias da Saude, Unidade Academica de Ciencias da Saude, Universidade do Extremo Sul Catarinense, Criciuma, Brazil. Laboratorio de Neurociencias, Programa de Pos-Graduacao em Ciencias da Saude, Unidade Academica de Ciencias da Saude, Universidade do Extremo Sul Catarinense, Criciuma, Brazil. Laboratorio de Neurociencias, Programa de Pos-Graduacao em Ciencias da Saude, Unidade Academica de Ciencias da Saude, Universidade do Extremo Sul Catarinense, Criciuma, Brazil. Laboratorio de Neurociencias, Programa de Pos-Graduacao em Ciencias da Saude, Unidade Academica de Ciencias da Saude, Universidade do Extremo Sul Catarinense, Criciuma, Brazil. Laboratorio de Fisiopatologia Experimental, Programa de Pos-Graduacao em Ciencias da Saude, Unidade Academica de Ciencias da Saude, Universidade do Extremo Sul Catarinense, Criciuma, Brazil. Laboratorio de Fisiopatologia Experimental, Programa de Pos-Graduacao em Ciencias da Saude, Unidade Academica de Ciencias da Saude, Universidade do Extremo Sul Catarinense, Criciuma, Brazil. Laboratorio de Fisiopatologia Experimental, Programa de Pos-Graduacao em Ciencias da Saude, Unidade Academica de Ciencias da Saude, Universidade do Extremo Sul Catarinense, Criciuma, Brazil. Laboratorio de Fisiopatologia Experimental, Programa de Pos-Graduacao em Ciencias da Saude, Unidade Academica de Ciencias da Saude, Universidade do Extremo Sul Catarinense, Criciuma, Brazil. Translational Psychiatry Research Group and Department of Clinical Medicine, Faculty of Medicine, Federal University of Ceara, Fortaleza, CE, Brazil. Laboratorio de Neurociencias, Programa de Pos-Graduacao em Ciencias da Saude, Unidade Academica de Ciencias da Saude, Universidade do Extremo Sul Catarinense, Criciuma, Brazil; Translational Psychiatry Program, Department of Psychiatry and Behavioral Sciences, McGovern Medical School, The University of Texas Health Science Center at Houston (UTHealth), Houston, TX, USA; Center of Excellence on Mood Disorders, Department of Psychiatry and Behavioral Sciences, McGovern Medical School, The University of Texas Health Science Center at Houston (UTHealth), Houston, TX, USA; Neuroscience Graduate Program, The University of Texas Graduate School of Biomedical Sciences at Houston, Houston, TX, USA.",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article"
     ],
     "DEP": "20161203",
     "PL": "England",
     "TA": "J Psychiatr Res",
     "JT": "Journal of psychiatric research",
     "JID": "0376331",
     "RN": [
          "0 (Enzyme Inhibitors)",
          "0 (Excitatory Amino Acid Antagonists)",
          "0 (Immunosuppressive Agents)",
          "690G0D6V8H (Ketamine)",
          "EC 2.7.1.1 (TOR Serine-Threonine Kinases)",
          "EC 2.7.1.1 (mTOR protein, rat)",
          "W36ZG6FT64 (Sirolimus)"
     ],
     "SB": "IM",
     "MH": [
          "Analysis of Variance",
          "Animals",
          "Drug Administration Routes",
          "Endoplasmic Reticulum Stress/*drug effects",
          "Enzyme Inhibitors/pharmacology",
          "Excitatory Amino Acid Antagonists/*pharmacology",
          "Immunosuppressive Agents/*pharmacology",
          "Ketamine/*pharmacology",
          "Male",
          "Prefrontal Cortex/*drug effects",
          "Rats",
          "Rats, Wistar",
          "Signal Transduction/*drug effects",
          "Sirolimus/*pharmacology",
          "TOR Serine-Threonine Kinases/*metabolism"
     ],
     "OTO": [
          "NOTNLM"
     ],
     "OT": [
          "Animal model",
          "ER stress",
          "Glutamatergic system",
          "Ketamine",
          "Major depressive disorder",
          "mTOR"
     ],
     "EDAT": "2016/12/27 06:00",
     "MHDA": "2017/09/20 06:00",
     "CRDT": [
          "2016/12/27 06:00"
     ],
     "PHST": [
          "2016/07/06 00:00 [received]",
          "2016/10/13 00:00 [revised]",
          "2016/12/01 00:00 [accepted]",
          "2016/12/27 06:00 [pubmed]",
          "2017/09/20 06:00 [medline]",
          "2016/12/27 06:00 [entrez]"
     ],
     "AID": [
          "S0022-3956(16)30738-5 [pii]",
          "10.1016/j.jpsychires.2016.12.002 [doi]"
     ],
     "PST": "ppublish",
     "SO": "J Psychiatr Res. 2017 Apr;87:81-87. doi: 10.1016/j.jpsychires.2016.12.002. Epub 2016 Dec 3.",
     "term": "hippocampus"
}